II. Evaluation: Severity Directs Migraine Headache Management
- See Migraine Abortive Medication
- See Migraine Prophylaxis
- See Migraine Management Clinic Schedule
- See Migraine Headache Care in the Emergency Department
- Migraine Disability Assessment Scale (MIDAS)
- Stratified Approach
- MIDAS Grade 1-2 (No or Mild Disability)
- Treat with simple Analgesics
- MIDAS Grade 3-4 (Moderate to Severe Disability)
- Treat with targeted Migraine medications
- MIDAS Grade 1-2 (No or Mild Disability)
III. Management: General
-
General Measures
- Practice Headache Self-Help Measures (e.g. Quiet dark room)
- Avoid Migraine Headache Triggers (e.g. Tyramine-Vasoactive Amines)
- Eliminate Rebound Migraine Factors (esp. Analgesics >10 days/month)
- Review Migraine Abortive Medications with best efficacy and safety for the given patient
- Avoid Opioid and Barbiturate agents (risk of Rebound Headache, and Substance Misuse)
-
Migraine Headache Prophylaxis is critical to the effective management of frequent Migraines
- See Migraine Headache Prophylaxis
- Frequent Migraine Headaches (4/month, 8 days/month)
- Prolonged Headaches >2 days with Disability
- Debilitating Headache despite acute Migraine abortive agents
- Intolerance or contraindications to acute Migraine abortive agents
- Analgesic Overuse Headaches or overuse of acute Migraine abortive agents
- Complicated Migraine Headache subtypes with prominent neurologic findings
- Headache protocols and precautions exist for specific patient cohorts
-
Exercise caution in elderly patients with Migraine Headache
- Consider Organic Headache (Secondary Headache)
- Triptans (and DHE) carry Vasocontrictor Contraindications below
- NSAIDS have numerous adverse effects in the elderly (e.g. GI Bleed, Acute Kidney Injury, Cardiovascular Risks)
- Gepants (e.g. Ubrogepant, Rimegepant, Zavegepant) may be associated with CYP450 related Drug Interactions
- Ditans (e.g. Lasmiditan) increase Somnolence and Fall Risk
IV. Management: Aura or mild to moderate early Acute Migraine (<2 hours, MIDAS 1-2)
- See Migraine Abortive Medication
- Advance Analgesics hourly (moving to moderate agents if not improving)
- NSAIDS (may be used in combination with Metoclopramide for greater effect)
- Combination agents (do not use Aspirin in children, increased GI irritation with Aspirin)
- Excedrin Migraine (Aspirin, Acetaminophen, Caffeine)
- Aspirin 1000 mg with Metoclopramide (see below)
- Alternatives for NSAID intolerant patients
- Acetaminophen 1000 mg
- Celecoxib (Celebrex, Elyxyb)
V. Management: Moderate Acute Migraine Headache (<2 to 4 hours, MIDAS 3) or refractory to above
- See Migraine Abortive Medication
- Consider administering at 1 hour for failed improvement with initial meds listed above
- Triptans are most effective when used at Migraine Headache onset
-
Migraine Abortive Medications (in combination with Anti-emetic, see below)
- First-Line
- Triptan agents (first-line, see below)
- Consider coadministration with NSAIDs
- Indomethacin is available as a suppository
- Other agents
- Intranasal Dihydroergotamine or DHE (Triptans are preferred, see below)
- Isometheptene (e.g. Midrin which also contains Acetaminophen and dichloralphenazone) may be effective
- However, Midrin is a controlled substance (schedule IV) due to the Sedative dichloralphenazone
- Generally avoided and largely replaced by Serotonin Agonists (esp. Triptans)
- Avoid Opioids
- Avoid Butalbital (e.g. Fiorinal)
- Barbiturate with poor efficacy
- Potentially addictive with risk of withdrawal
- First-Line
-
Antiemetic
- Precautions
- All dopamine Antagonists risk Extrapyramidal Side Effects (warn patients to stop agent if occurs)
- First-line
- Metoclopramide (Reglan, enhances abortive medication absorption)
- Prochlorperazine (Compazine)
- Other Anti-emetics (some available as suppositories)
- Dimenhydrinate
- Hydroxyzine (Atarax)
- 5-HT3 Receptor Antagonist (e.g. Ondansetron)
- Although available as ODT, and effective in Nausea, less effective in Migraine Headache
- Phenergan
- Also a dopamine Antagonist (but may be less effective in Migraine Headache)
- Precautions
VI. Management: Severe Acute Migraine Headache (2-6 hours, MIDAS 4) or refractory to above
- See Emergency Department Migraine Headache Care
- See Migraine Abortive Medications
- Antiemetic as above
-
Serotonin Agonist
-
Triptans (first-line, preferred)
- Sumatriptan (Imitrex) - subcutaneous form is more effective than oral, intranasal
- Rizatriptan (Maxalt MLT) - orally disintegrating tablets
- Zolmitriptan (Zomig) - orally disintegrating tablets
- Almotriptan (Axert)
- Eletriptan (Relpax)
-
Triptans (longer acting agents for recurrent Migraines)
- Naratriptan (Amerge, generic)
- Frovatriptan (Frova)
-
Dihydroergotamine or DHE (e.g. Migranal Nasal Spray, second-line)
- Triptans are preferred over Dihydroergotamine
- Do not use within 24 hours of a Triptan
- Nausea is common, and reduce dose if Leg Cramps or Paresthesias may occur
-
Triptans may have inadequate response in up to one third of Migraine Headache patients
- Consider switching to another Triptan
- Consider combining with NSAIDs
- Consider Rebound Headache or other Headache Causes
- Consider third-line agents (see below)
-
Triptans (first-line, preferred)
- Third-line Agents (very expensive, and overall lower efficacy than Triptans)
- Gepant (CGRP receptor blocker)
- Ditan (Selective Serotonin 5-Hydroxytryptamine receptor 1F agonst or 5-HT1F Agonist)
- Schedule V due to euphoria and Hallucinations
- Lasmiditan (Reyvow)
VII. Management: Severe Acute Refractory Migraine Headache (6 to 72 hours, MIDAS 4)
VIII. Prevention
- See Migraine Prophylaxis
- See Migraine Headache Triggers (e.g. Tyramine-Vasoactive Amines)
- See Rebound Migraine Factors (esp. Analgesics >10 days/month)
IX. Contraindications: Vasoconstrictors (e.g. Triptans, DHE)
- Contraindications to Vasoconstrictors (e.g. Triptan, DHE)
- Coronary Artery Disease
- Cerebrovascular Accident history
- Hemiplegic Migraines
- Basilar Migraines
- Pregnancy
- Alternative Non-Vasoconstrictive Agents
- Excedrin Migraine (Acetaminophen, Aspirin, Caffeine)
- NSAIDS
- Dopamine Antagonists (e.g. Metoclopramide or Prochlorperazine)
- Gepant (e.g. Ubrogepant, Rimegepant, Zavegepant)
- Ditan (e.g. Lasmiditan)
X. References
- Jackson (1998) CMEA Internal Medicine Lecture,San Diego
- Mayans (2018) Am Fam Physician 97(4): 243-51 [PubMed]
- Moore (1997) Am Fam Physician 56(8):2039-48 [PubMed]
- Noble (1997) Am Fam Physician 56(9):2279-86 [PubMed]
- Polizzotto (2002) J Fam Pract 51(2):161-7 [PubMed]
- Silberstein (2004) Lancet 363:381-91 [PubMed]
- Wiley (2025) Am Fam Physician 111(4): 317-27 [PubMed]